IGF-1 Therapy in Patients With Cystic Fibrosis

NCT00566241 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment

Conditions

Cystic Fibrosis

Interventions

DRUG: recombinant human IGF-1
DRUG: Placebo

Sponsor

Stony Brook University